Cite Filings / ATOS / 0001193125-26-131807

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

ATOSSA THERAPEUTICS, INC. Filed 2026-03-30 Acc 0001193125-26-131807

Documents 1

DEF 14A Proxy Statement , atos-20260330.htm

Around this filing

2026-03-31 4 President & CEO acquired 65,000 shares (grant or award)
2026-03-30 4 Chief Financial Officer acquired 63,000 shares (grant or award)
2026-03-30 ARS Annual Report to Security Holders
2026-03-30 DEF 14A Proxy Statement
2026-03-25 10-K Annual Report
2026-03-25 8-K Exhibits
2025-12-22 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading atos-20260330.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…